1981
DOI: 10.1016/0014-5793(81)80443-7
|View full text |Cite
|
Sign up to set email alerts
|

Glycerolphosphate acyltransferase, dihydroxyacetonephosphate acyltransferase and carnitine palmitoyltransferase in a glycogen storage disease (gsd/gsd) rat

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1982
1982
2020
2020

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 15 publications
(19 reference statements)
0
2
0
Order By: Relevance
“…In preliminary experiments (not shown) the same was found to hold for this activity in brown-adipocyte mitochondrial fractions. Because mitochondrial GPAT has very low activity with unsaturated acyl-CoA substrates, it has been found convenient to assay for microsomal GPAT in liver extracts with oleoyl-CoA as substrate, as well as assaying for NEM-sensitive activity with palmitoyl-CoA (Saggerson & Topping, 1981). The same was found to be true for brown adipocytes, in that 10 mM-NEM inhibited more than 9500 of GPAT activity measured with oleoyl-CoA in brown-adipocyte homogenates or in any subcellular fraction (results not shown).…”
Section: Resultsmentioning
confidence: 99%
“…In preliminary experiments (not shown) the same was found to hold for this activity in brown-adipocyte mitochondrial fractions. Because mitochondrial GPAT has very low activity with unsaturated acyl-CoA substrates, it has been found convenient to assay for microsomal GPAT in liver extracts with oleoyl-CoA as substrate, as well as assaying for NEM-sensitive activity with palmitoyl-CoA (Saggerson & Topping, 1981). The same was found to be true for brown adipocytes, in that 10 mM-NEM inhibited more than 9500 of GPAT activity measured with oleoyl-CoA in brown-adipocyte homogenates or in any subcellular fraction (results not shown).…”
Section: Resultsmentioning
confidence: 99%
“…Laboratory findings in affected rats which have not been reported in the human patient include diminished hepatic lipogenesis and cholesterogenesis, a reduction in plasma triacylgtycerol and lactate levels, an altered plasma amino acid composition and an increased concentration of biliary acids . Changes in liver lipid metabolism are illustrated by diminished glycerolphosphate ac3~ltransferase and dihydroxyacetonephosphate acyltransferase activities and an increased carnitine palmitoyltransferase activity in liver tissue (Saggerson and Topping, 1981). Biochemical abnormalities could not be detected in heterozygous animals (Malthus et al, t980).…”
Section: Gsd VIIImentioning
confidence: 99%